Rapid Micro Biosystems Announces New Vice President of Global Sales
November 27 2018 - 7:00AM
Rapid Micro Biosystems, a leading provider of automated,
non-destructive, rapid microbial detection, is pleased to announce
the appointment of Scott White as Vice President of Global Sales.
He reports directly to the company’s CEO, Robert Spignesi.
Mr. White has over 20 years of sales experience in the
healthcare and technology industries. Mr. White spent 7 years
in progressive roles at Intuitive Surgical (NASDAQ:ISRG), including
Area Vice President for the US Southeast / Mid-Atlantic
region. In this role, he led a 120-member sales team across 7
states and 270+ hospitals. Mr. White grew the region to
consecutive #3 and #2 rankings in worldwide sales, and #1 in new
technology sales, generating $200 million in revenue. Mr.
White has also served as President of Compass Surgical Partners, a
private firm that manages ambulatory surgical centers, Managing
Partner of Surgery Center Development Co, a multi-specialty
outpatient surgical center business, and in multiple sales roles at
C.R. Bard, GlaxoSmithKline and Verizon.
“I am excited to welcome Scott to our executive management
team,” said Mr. Spignesi. “He brings extensive experience leading
and growing sales organizations and selling market-disruptive
technologies. Scott will be instrumental in leading our
growth as we continue to expand the Growth Direct™ system to
leading companies globally.”
“I am incredibly honored to be part of Rapid Micro Biosystems
and partner with some of the world’s leading healthcare companies,”
said Mr. White. “As we deliver our Growth Direct™ system to
the market, our entire team is committed to realizing our mission
of being the trusted standard in microbial automation.”
Mr. White holds an MBA in Finance from the University of Miami,
and a BS in Business Administration from the University of
Florida.
About Rapid Micro BiosystemsRapid Micro
Biosystems delivers the Growth Direct™ System, an automated,
non-destructive rapid detection and enumeration technology based on
the compendial method for microbial quality control in
pharmaceutical manufacturing. The system automates and
accelerates detection and enumeration in the areas of sterility
testing, environmental monitoring, and bioburden testing,
eliminating manual steps and analysis. The detection
technology, first developed and patented by Dr. Don Straus, Ph.D.,
uses the natural auto-fluorescence of microbes and requires no
reagents. For more information about Rapid Micro Biosystems visit
www.rapidmicrobio.com.
Intuitive Surgical (NASDAQ:ISRG)
Historical Stock Chart
From Apr 2024 to May 2024
Intuitive Surgical (NASDAQ:ISRG)
Historical Stock Chart
From May 2023 to May 2024